Amy Hauck Newman

Amy Hauck Newman

Amy Hauck Newman in 2020

Amy Hauck Newman is an American medicinal chemist renowned for her contributions to the field of neuropharmacology and the development of novel therapeutic agents targeting the dopamine receptor system. Her work has significantly advanced the understanding of dopaminergic mechanisms and their implications in neuropsychiatric disorders.

Early Life and Education

Amy Hauck Newman was born in the United States. She pursued her undergraduate studies in chemistry at Mary Baldwin University, where she developed a keen interest in the intersection of chemistry and biology. She continued her education at the University of Maryland, College Park, earning a Ph.D. in medicinal chemistry. Her doctoral research focused on the synthesis and evaluation of compounds that interact with the central nervous system.

Career

Newman began her career at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), where she has held various positions. Her research at NIDA has been pivotal in the design and synthesis of ligands for the dopamine transporter and receptors, which are crucial in the study of addiction and schizophrenia.

Research Contributions

Newman's research has primarily focused on the development of selective ligands for the dopamine D3 receptor, a target implicated in several neuropsychiatric conditions. Her work has led to the discovery of compounds that have potential therapeutic applications in treating substance use disorders and Parkinson's disease.

Her team has also explored the structure-activity relationships of these ligands, providing insights into their binding mechanisms and functional selectivity. This research has contributed to the broader understanding of dopamine receptor pharmacology and its role in modulating neurotransmission.

Awards and Honors

Throughout her career, Newman has received numerous accolades for her scientific achievements. She has been recognized by the American Chemical Society and other professional organizations for her contributions to medicinal chemistry and neuropharmacology.

Personal Life

Amy Hauck Newman is married and has children. She balances her professional commitments with her family life, often advocating for the importance of work-life balance in academia and research.

Related Pages

• Dopamine receptor
• Neuropharmacology
• National Institute on Drug Abuse
• Medicinal chemistry